Chemicals & Advanced Materials Global On demand · 24-48h

Global GST Purification Kits Market Strategic Research Report

Global GST Purification Kits Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global GST Purification Kits Market
$73.372025
9.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Batch Gravity Kit, Spin Column Kit, Magnetic Bead Kit, Prepacked FPLC Column, 96-Well Plate Kit, Bulk Resin Pack

By Application: GST-Tagged Protein Purification, Soluble Expression Screening, Pull-down Interaction Assay, Antigen or Immunogen Preparation, Enzyme and Functional Assay Prep, Structural Biology Sample Prep, Proteomics Workflow Prep

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Cytiva, Merck, Takara Bio, GenScript, G-Biosciences, GoldBio, Abcam, APExBIO, Beyotime, Yeasen, Solarbio, Coolaber, Aladdin, MedChemExpress, Cube Biotech, UBPBio, Beaver Biomedical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 137 pages
Market size 2025
$73.37
Million USD
Forecast CAGR
9.2%
2025-2032
Forecast 2032
$135.9
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global GST Purification Kits market size is predicted to grow from US$ 73.37 million in 2025 to US$ 136 million in 2032; it is expected to grow at a CAGR of 9.2% from 2026 to 2032.

The GST purification kit uses immobilized reduced glutathione (GSH) as the affinity ligand and is designed for research-grade capture, washing, and elution of GST-tagged fusion proteins from bacterial, yeast, insect, or mammalian cell lysates, including directly compatible consumables. Estimated gross margin is 58%.

Demand is primarily driven by recombinant protein expression, structural and functional studies, antigen preparation, and protein interaction experiments. The GST tag helps improve the solubility of certain target proteins and allows one-step purification under mild conditions using glutathione-affinity media, making it a commonly used tag system in research and early-stage drug discovery. Compared with His tags, the GST system is smaller in scale but maintains stable demand in pull-down assays and applications requiring high protein activity. Product formats are evolving from traditional bulk resin and gravity columns toward centrifuge columns, magnetic beads, pre-packed FPLC columns, and 96-well plates. Price differences mainly arise from matrix flow rate, binding capacity, pre-packing, completeness of buffers, and automation compatibility. Market growth is driven by biopharmaceutical R&D, proteomics, synthetic biology, and expansion of early-stage CRO/CDMO development workflows. In the short term, this category is unlikely to reach the scale of industrial resin-level markets, but strong reagent consumable repeat purchases, abundant SKUs, and sensitivity to experimental stability and brand validation allow leading brands to maintain high gross margins.

Key Questions Addressed in this Report

What is the 10-year outlook for the global GST Purification Kits market?

What factors are driving GST Purification Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GST Purification Kits market opportunities vary by end market size?

How does GST Purification Kits break out by Type, by Application?

This report presents a comprehensive overview of the global GST Purification Kits market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Batch Gravity Kit
  • Spin Column Kit
  • Magnetic Bead Kit
  • Prepacked FPLC Column
  • 96-Well Plate Kit
  • Bulk Resin Pack

Segment by Sample Source

  • Bacterial Lysate
  • Yeast Lysate
  • Mammalian Insect Lysate
  • Purified Protein Mixture
  • Other Samples

Segment by Kit Completeness

  • Resin Only
  • Column plus Eluent
  • Complete Lysis-to-Elution Kit
  • Pull-down Kit
  • Buffer Set Accessory

Segment by Application

  • GST-Tagged Protein Purification
  • Soluble Expression Screening
  • Pull-down Interaction Assay
  • Antigen or Immunogen Preparation
  • Enzyme and Functional Assay Prep
  • Structural Biology Sample Prep
  • Proteomics Workflow Prep

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global GST Purification Kits market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in GST-Tagged Protein Purification, Soluble Expression Screening, Pull-down Interaction Assay evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global GST Purification Kits Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$73.37
2025
Forecast
$135.9
2032
CAGR
9.2%
2025–2032
Regiões
5
global
Key companies
Thermo Fisher ScientificCytivaMerckTakara BioGenScriptG-BiosciencesGoldBioAbcam
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Batch Gravity KitSpin Column KitMagnetic Bead KitPrepacked FPLC Column96-Well Plate KitBulk Resin Pack
By Application
GST-Tagged Protein PurificationSoluble Expression ScreeningPull-down Interaction AssayAntigen or Immunogen PreparationEnzyme and Functional Assay PrepStructural Biology Sample PrepProteomics Workflow Prep

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Batch Gravity Kit
  • 3.1.3 Spin Column Kit
  • 3.1.4 Magnetic Bead Kit
  • 3.1.5 Prepacked FPLC Column
  • 3.1.6 96-Well Plate Kit
  • 3.1.7 Bulk Resin Pack
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 GST-Tagged Protein Purification
  • 4.1.3 Soluble Expression Screening
  • 4.1.4 Pull-down Interaction Assay
  • 4.1.5 Antigen or Immunogen Preparation
  • 4.1.6 Enzyme and Functional Assay Prep
  • 4.1.7 Structural Biology Sample Prep
  • 4.1.8 Proteomics Workflow Prep
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cytiva
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Merck
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Takara Bio
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GenScript
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 G-Biosciences
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 GoldBio
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Abcam
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 APExBIO
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Beyotime
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Yeasen
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Solarbio
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Coolaber
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Aladdin
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 MedChemExpress
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Cube Biotech
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 UBPBio
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Beaver Biomedical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global GST Purification Kits market?
The global GST Purification Kits market is estimated at US$ 73.37 million in 2025 (base year) and is projected to reach US$ 136 million by 2032.
What is the forecast CAGR for the GST Purification Kits market?
The market is expected to grow at a CAGR of 9.2% from 2026 to 2032, expanding from US$ 73.37 million in 2025 to US$ 136 million in 2032, roughly 1.9 times its base-year value.
What is GST Purification Kits?
The GST purification kit uses immobilized reduced glutathione (GSH) as the affinity ligand and is designed for research-grade capture, washing, and elution of GST-tagged fusion proteins from bacterial, yeast, insect, or mammalian cell lysates, including directly compatible consumables. Estimated gross margin is 58%.
What are the main segments of the GST Purification Kits market by type?
By type, the market is segmented into Batch Gravity Kit, Spin Column Kit, Magnetic Bead Kit, Prepacked FPLC Column, 96-Well Plate Kit and Bulk Resin Pack.
Which applications drive demand in the GST Purification Kits market?
Key applications covered include GST-Tagged Protein Purification, Soluble Expression Screening, Pull-down Interaction Assay, Antigen or Immunogen Preparation, Enzyme and Functional Assay Prep, Structural Biology Sample Prep and Proteomics Workflow Prep.
Who are the key players in the GST Purification Kits market?
Key players profiled include Thermo Fisher Scientific, Cytiva, Merck, Takara Bio, GenScript, G-Biosciences, GoldBio and Abcam, among 18 companies covered in total.
Which regions and countries are covered for GST Purification Kits?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the GST Purification Kits market?
Demand is primarily driven by recombinant protein expression, structural and functional studies, antigen preparation, and protein interaction experiments.
Who should buy the GST Purification Kits market report?
The report is intended for manufacturers and solution providers, distributors and end users in GST-Tagged Protein Purification, Soluble Expression Screening and Pull-down Interaction Assay, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the GST Purification Kits market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.